Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascular Responses to Hypoxia in Aging and Menopause
NCT06417177Phase 1Recruiting
- Sponsor
- University of Missouri
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of propranolol and vibegron (3 arms), sponsored by University of Missouri. Primary endpoint: Forearm blood flow at 5 minutes. Started Jun 2024; status: recruiting.
02
Drugs
propranololvibegron
Beyond the preview
Go deeper on NCT06417177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06417177.